(Q36373061)

13 August 2017

1 reference

title

Recent advances in the design of HIV proteinase inhibitors (English)

1 reference

13 August 2017

main subject

HIV protease inhibitors

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1642479

20 October 2022

1 reference

https://api.crossref.org/works/10.1016/0166-3542(92)90022-W

20 October 2022

author name string

J. A. Martin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1642479

20 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1642479

20 October 2022

publication date

1 April 1992

1 reference

full work available at URL

13 August 2017

https://api.elsevier.com/content/article/PII:016635429290022W?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0166-3542(92)90022-W

https://api.elsevier.com/content/article/PII:016635429290022W?httpAccept=text/plain

20 October 2022

1 reference

https://api.crossref.org/works/10.1016/0166-3542(92)90022-W

20 October 2022

1 reference

13 August 2017

volume

17

1 reference

13 August 2017

issue

4

1 reference

13 August 2017

page(s)

265-278

1 reference

Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)

13 August 2017

cites work

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/citations/10.1126/SCIENCE.6189183

HIV-1 protease specificity of peptide cleavage is sufficient for processing of gag and pol polyproteins

3

1 reference

https://api.crossref.org/works/10.1016/0166-3542(92)90022-W

Inhibition of human immunodeficiency virus 1 protease in vitro: rational design of substrate analogue inhibitors

20 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0166-3542(92)90022-W

Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS)

20 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0166-3542(92)90022-W

Selective phosphinate transition-state analogue inhibitors of the protease of human immunodeficiency virus

20 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0166-3542(92)90022-W

Structure-based, C2 symmetric inhibitors of HIV protease

20 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0166-3542(92)90022-W

HTLV-III gag protein is processed in yeast cells by the virus pol-protease

20 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0166-3542(92)90022-W

Activity of purified biosynthetic proteinase of human immunodeficiency virus on natural substrates and synthetic peptides

20 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0166-3542(92)90022-W

Benzocycloalkyl amines as novel C-termini for HIV protease inhibitors

20 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0166-3542(92)90022-W

A synthetic HIV-1 protease inhibitor with antiviral activity arrests HIV-like particle maturation

20 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0166-3542(92)90022-W

Peptide substrates and inhibitors of the HIV-1 protease

20 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0166-3542(92)90022-W

A structural model for the retroviral proteases.

20 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0166-3542(92)90022-W

Complete nucleotide sequence of the AIDS virus, HTLV-III

20 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0166-3542(92)90022-W

Hydroxyethylamine analogues of the p17/p24 substrate cleavage site are tight-binding inhibitors of HIV protease

20 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/0166-3542(92)90022-W

Effect of hydroxyl group configuration in hydroxyethylamine dipeptide isosteres on HIV protease inhibition. Evidence for multiple binding modes

20 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0166-3542(92)90022-W

Effective blocking of HIV-1 proteinase activity by characteristic inhibitors of aspartic proteinases

20 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/0166-3542(92)90022-W

Rational design of peptide-based HIV proteinase inhibitors

20 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0166-3542(92)90022-W

Enzymatic activity of a synthetic 99 residue protein corresponding to the putative HIV-1 protease

20 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/0166-3542(92)90022-W

L-687,908, a potent hydroxyethylene-containing HIV protease inhibitor

20 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/0166-3542(92)90022-W

Conserved folding in retroviral proteases: crystal structure of a synthetic HIV-1 protease

20 October 2022

26

1 reference

https://api.crossref.org/works/10.1016/0166-3542(92)90022-W

20 October 2022

Identifiers

1 reference

13 August 2017

1 reference